Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

NetScientific to delist from AIM and become a private company following strategic review

The firm said that it had concluded following the review that a revised strategy was required to reduce its central functions and costs “significantly” so as much of its remaining cash as possible could be allocated to its portfolio compani

NetScientific PLC (LON:NSCI) has said it is looking to delist from AIM and re-register as a private company following a strategic review into its operations.

The firm, which invests in development-stage medical and healthcare businesses, said that it had concluded following the review that a revised strategy was required to reduce its central functions and costs “significantly” to enable as much of its remaining cash as possible be allocated to its portfolio companies.

READ: NetScientific says continuing to assess all remaining strategic options after closing formal sale process​

The company also said it had failed to generate any interest in a possible sale or to elicit and offers for the firms in its portfolio, adding that its cash resources as of 31 December were £3.3mln.

Shares were down 44% at 4.5p.​​

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK